Effect of long-term therapy with short-acting β2-agonist on left ventricle systolic function in patients with chronic obstructive pulmonary disease

T. O. Pertseva, T. S. Onyshchenko, L. I. Konopkina (Dnipropetrovsk, Ukraine)

Source: Annual Congress 2004 - Clinical and behavioural consequences of COPD
Session: Clinical and behavioural consequences of COPD
Session type: Poster Discussion
Number: 214
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. O. Pertseva, T. S. Onyshchenko, L. I. Konopkina (Dnipropetrovsk, Ukraine). Effect of long-term therapy with short-acting β2-agonist on left ventricle systolic function in patients with chronic obstructive pulmonary disease. Eur Respir J 2004; 24: Suppl. 48, 214

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)>
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Assessment of right ventricular diastolic function in chronic obstructive lung disease
Source: Annual Congress 2010 - Lung imaging
Year: 2010


The relationship between chronic obstructive pulmonary disease exacerbations and right ventricular function
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Resistin, 8-isorpostanes and stress right ventricular diastolic dysfunction -   predictors for exacerbations in non-severe chronic obstructive pulmonary disease patients
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015

Complex right ventricular response to pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Prognostic value of ventricular volumes and function in patients with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012

Cardio-pulmonary-exercise testing, stress-induced right ventricular diastolic dysfunction and exercise capacity in non-severe chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


Pulmonary hypertension and right ventricular impairment in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001

Echocardiographic predictors of stress induced right ventricular diastolic dysfunction in non-severe  chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function
Year: 2020




Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Effects of a respiratory rehabilitation program over pulmonary hypertension (PH) and other right ventricular function measurements in a chronic obstructive pulmonary disease (COPD) population
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009

Echocardiographic evaluation of right ventricular diastolic function in patients with chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with cor pulmonale
Source: Eur Respir J 2004; 24: Suppl. 48, 112s
Year: 2004

Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease>
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

The haemodynamic and gas-exchange responses to exercise in pulmonary hypertension, chronic obstructive pulmonary disease and left heart ventricle failure: similarities and differences
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018